JY
BDSX icon

Jeff Yass’s Biodesix BDSX Stock Holding History

Jeff Yass’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,800
Closed -$215K – 13381
2026
Q1 		$215K Buy
14,800
+2,300
+18% +$28.5K ﹤0.01% 11552
2025
Q4 		$85K Sell
12,500
-3,500
-22% -$25.8K ﹤0.01% 11541
2025
Q3 		$121K Buy
+16,000
New +$123K ﹤0.01% 11445
2022
Q4 		– Sell
-1,330
Closed -$34K – 12404
2022
Q3 		$34K Sell
1,330
-190
-13% -$7.33K ﹤0.01% 12406
2022
Q2 		$50K Buy
+1,520
New +$49.4K ﹤0.01% 11972
2022
Q1 		– Sell
-605
Closed -$64K – 12969
2021
Q4 		$64K Buy
+605
New +$79K ﹤0.01% 12424

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jeff Yass's BDSX Position: Q2 2026 in Review

Jeff Yass sold out of Biodesix (BDSX) in Q2 2026, closing a stake of 23,090 shares — an estimated $335K sold.

Jeff Yass first reported a position in BDSX in Q1 2023 and held it in 7 quarters. The position peaked at $1.71M in Q4 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Jeff Yass reported no remaining Biodesix position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 23,090 Biodesix shares in Q2 2026, an estimated $335K.
  • Jeff Yass first reported a position in Biodesix in Q1 2023 and held it in 7 quarters.
  • Jeff Yass's Biodesix position peaked at $1.71M in Q4 2024.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.